Metformin and Chemotherapy in Treating Patients With Stage III-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Seiko Yamada
University of Chicago
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Alabama
Birmingham, Alabama, United States
- Mitchell Cancer Institute - University of South Alabama
Mobile, Alabama, United States
- City of Hope
Duarte, California, United States
- Nch Medical Group- Northwest Community Hospital
Arlington Heights, Illinois, United States
- Rush University Medical Center
Chicago, Illinois, United States
- University of Chicago
Chicago, Illinois, United States
- Decatur Memorial Hospital
Decatur, Illinois, United States
- Northshore University Healthsystem
Evanston, Illinois, United States
- Ingalls Memorial Hospital
Harvey, Illinois, United States
- Mayo Clinic
Rochester, Minnesota, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 25 Feb 2015
- Primary completion
- 27 Oct 2022
- Completion
- 8 Oct 2024
- Last update posted
- 27 Mar 2026
- Registered enrollment
- 111
- Registry id
- NCT02122185
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.